Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children With Sickle Cell Disease

NCT06578507 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Theravia